Top

Cancer Causes & Control

Published in:

01-03-2006 | Original Paper

Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?

Authors: Monika Janda, John B. Lowe, Mark Elwood, Ian T. Ring, Philippa H. Youl, Joanne F. Aitken

Published in: Cancer Causes & Control | Issue 2/2006

Abstract

Objective

To compare during the first 12 months of a 3-year randomised community-based trial of population screening for melanoma three methods of screening delivery: skin screening within day-to-day primary care (Group A); screening in dedicated skin screening clinics either organised privately by local physicians (Group B); or organised centrally with participants referred back to their physicians for definitive diagnosis and management (Group C).

Methods

The trial involved 18 regional communities in Queensland, Australia. Of the nine communities randomised to the intervention group, three communities were allocated to each of the Groups A, B or C. All intervention communities received a community education programme and an education and support programme for primary care physicians. The self-reported prevalence of clinical skin examination was assessed by surveying 3,110 residents (66.9% participation rate) aged ≥30 years by telephone at baseline, and 14,060 residents (70.9% participation rate) by self-administered mailed questionnaire at 12-month follow-up.

Results

At baseline the prevalence of skin screening did not differ between intervention and control communities. At 12-month follow-up, participants within intervention communities reported skin screening significantly more frequently (20.9% versus 10.9%; p<0.001). Within intervention communities, the prevalence of clinical skin examinations in Group A was similar to that of control communities (12.6% and 10.9%; p = 0.33). Communities in Group B (16.5%; p = 0.001) and Group C (27.1%; p<0.001) reported significantly higher prevalence of clinical examinations than the control group.

Conclusions

The provision of centrally organised skin screening clinics significantly increases skin screening rates and may have relevance for future melanoma control programmes.

U.S. Census Bureau. Available at http://www.census.gov. Accessed April 20, 2005

Jemal, A, Murray, T, Ward, E, et al. 2005Cancer Statistics, 2005CA Cancer J Clin551030PubMed

Australian Institute of Health and Welfare (AIHW) &Australasian Association of Cancer Registries (AACR) 2003. Cancer in Australia 2000. AIHW Cat No. CAN 18 AIHW (Cancer Series no. 23) Canberra

Elwood, M 1994Screening for melanoma and options for its evaluationJ Med Screen12238PubMed

Marks, R 2002The changing incidence and mortality of melanoma in AustraliaRecent Results Cancer Res160113121PubMed

American Cancer Society. Available at: http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_Can_melanoma_be_found_ early_50.asp?sitearea=Accessed April 20, 2005

American College of Preventive Medicine. Available at http://www.acpm.org/cpsskincancer.htm Accessed April 20, 2005

Feightner JW (1994) Prevention of skin cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa: Health Canada, pp. 850–859

U.S. Preventive Services Task Force. Recommendations and Rationale Screening for Skin Cancer. Available at http://www.ahrq.gov/clinic/ajpmsuppl/skcarr.htm Accessed April 20, 2005

10.

The Cancer Council of Australia (2004) National Cancer Prevention Policy 2004–2006. Available at http://www.cancer.org.au/documents/NatCancerPreventPol_04-06.pdf Accessed April 20, 2005

11.

Girgis, A, Clarke, P, Burton, R, Sanson-Fisher, R 1996Screening for melanoma by primary health care physicians: a cost-effectiveness analysisJ Med Screen34753PubMed

12.

Burton, R, Howe, C, Adamson, L, et al. 1998General practitioner screening for melanoma: sensitivity, specificity and effect of trainingJ Med Screen5156161PubMed

13.

Freedberg, K, Geller, A, Miller, D, Lew, R, Koh, H 1999Screening for malignant melanoma: a cost-effectivness analysisJ Am Acad Dermatol41738745CrossRefPubMed

14.

Pathman, DE, Williams, ES, Konrad, TR 1996Rural physician satisfaction: its sources and relationship to retentionJ Rural Health1236677PubMed

15.

Rolfe, IE, Pearson, SA, O’Connell, DL, Dickinson, JA 1995Finding solutions to the rural doctor shortage: the roles of selection versus undergraduate medical education at NewcastleAust NZ J Med25512517

16.

Rabinowitz, HK, Diamond, JJ, Markham, FW, Hazelwood, CE 1999A program to increase the number of family physicians in rural and underserved areas: impact after 22 yearsJAMA28125560CrossRefPubMed

17.

Aitken, JF, Elwood, JM, Lowe, JB, Firman, DW, Balanda, KP, Ring, IT 2002A randomised trial of population screening for melanomaJ Med Screen93337CrossRefPubMed

18.

Lowe, JB, Ball, J, Lynch, BM, et al. 2004Achieving community participation in a community-based melanoma screening program by volunteer facilitated program deliveryHealth Promot Int19437444CrossRefPubMed

19.

Janda, M, Elwood, MJ, Firman, D, Lowe, JB, Youl, P, Aitken, JF 2004Prevalence of skin screening by general practitioners in regional QueenslandMed J Aust1801015PubMed

20.

Aitken, JF, Janda, M, Lowe, JB, et al. 2004Prevalence of whole-body skin self-examination in a population at high risk for skin cancerCancer Causes Control15453463CrossRefPubMed

21.

Aitken, JF, Youl, P, Janda, M, Elwood, M, Ring, I, Lowe, J 2004Comparability of skin screening histories obtained by telephone interviews and mailed questionnaires – A randomised crossover studyAm J Epidemiol160598604CrossRefPubMed

22.

Shah, BV, Barnwell, BG, Bieler, GS 1996SUDAAN User’s ManualResearch Triangle InstituteNorth Carolina

23.

Legler, J, Meissner, HI, Coyne, C, Breen, N, Cholette, V, Rimer, BK 2002The effectiveness of interventions to promote mammography among women with historically lower rates of screeningCancer Epidemiol Biomarkers Prev115971PubMed

24.

Janda, M, Youl, PH, Lowe, JB, Elwood, M, Ring, IT, Aitken, JF 2004Attitudes and intentions in relation to skin checks for early signs of skin cancerPrev Med391118CrossRefPubMed

25.

Geller, AC, Zhang, Z, Sober, AJ, et al. 2003The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985–1999J Am Acad Dermatol483441CrossRefPubMed

26.

Carli, P, Giorgi, V, Giannotti, B, et al. 2003Skin cancer day in Italy: method of referral to open access clinics and tumor prevalence in the examined populationEur J Dermatol137679PubMed

27.

Pehamberger, H, Binder, M, Knollmayer, S, Wolff, K 1993Immediate effects of a public education campaign on prognostic features of melanomaJ Am Acad Dermatol29106109PubMed

28.

Rampen, FH, Berretty, PJ, Huystee, BE, Kiemeney, LA, Nijs, CH 1993Lack of selective attendance of participants at skin cancer/melanoma screening clinicsJ Am Acad Dermatol29423427PubMed

29.

Breast Screen Queensland: Available at: http://www.health.qld. gov.au/breastscreen/history.htm Accessed April 20, 2005

30.

Hanrahan, PF, Hersey, P, D’Este, CA 1998Factors involved in presentation of older people with thick melanomaMed J Aust169410414PubMed

31.

Jemal, A, Devesa, S, Fears, T, Hartage, P 2000Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United StatesJ Natl Cancer Inst8823982424

32.

Koh, HK, Miller, DR, Geller, AC, Clapp, RW, Mercer, MB, Lew, RA 1992Who discovers melanoma? Patterns from a population-based surveyJ Am Acad Dermatol26914919PubMed

33.

Schofield, T, Connell, RW, Walker, L, Wood, J, Butland, D 2000Understanding men’s health and illness: a gender-relations approach to policy, research, and practiceJ Am Coll Health48247256PubMed

34.

Aitken, JF, Youl, PH, Janda, M, et al. 2004Validity of self-reported skin screening historiesAm J Epidemiol15910981105CrossRefPubMed

Title: Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?
Authors: Monika Janda
John B. Lowe
Mark Elwood
Ian T. Ring
Philippa H. Youl
Joanne F. Aitken
Publication date: 01-03-2006
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 2/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-005-0419-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2006

Diet After Diagnosis and the Risk of Prostate Cancer Progression, Recurrence, and Death (United States)

Causal Effects of Smokeless Tobacco on Mortality in CPS-I and CPS-II?

Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States)

Dietary Phytoestrogen, Serum Enterolactone and Risk of Prostate Cancer: The Cancer Prostate Sweden Study (Sweden)

Comparative Epidemiology of Breast Cancer Among Men and Women in the US, 1996 to 2000

Population-based Mammography Screening and Breast Cancer Incidence in New South Wales, Australia

Keynote webinar | Spotlight on antibody–drug conjugates in cancer